A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
Clinical trial NCT04961996 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04961996
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-27
- Primary completion
- 2025-08-08
- Enrollment
- 4170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.